Amneal Pharmaceuticals Inc (NYSE:AMRX)
| 4.21 Delayed Data As of Sep 29 |  -0.12 / -2.77%Today’s Change | 1.24 Today|||52-Week Range 4.74 | +111.56% Year-to-Date |
Latest AMRX News | Press Releases
No recent news for Amneal Pharmaceuticals Inc.
Today’s Trading
| Previous close | 4.33 |
| Today’s open | 4.31 |
| Day’s range | 4.15 - 4.31 |
| Volume | 1,217,595 |
| Average volume (3 months) | 1,128,654 |
| Market cap | $1.3B |
Data as of 4:00pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | -1,307.85% |
| Earnings growth (this year) | -27.65% |
| Earnings growth (next 5 years) | +11.30% |
| Revenue growth (last year) | +5.67% |
| P/E ratio | NM |
| Price/Sales | 0.14 |
| Price/Book | 2.14 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VRNAVerona Pharma PLC | -0.22 | -1.33% |
| SMMTSummit Therapeutics ... | +0.05 | +2.73% |
| ---- | ||
| TGTXTG Therapeutics Inc | -0.41 | -4.73% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | November 8, 2023 |
| EPS forecast (this quarter) | $0.11 |
| Annual revenue (last year) | $2.2B |
| Annual profit (last year) | -$130.0M |
| Net profit margin | -5.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bridgewater, New Jersey |
Forecasts
